Several Indian companies, including Larsen & Toubro, Godrej Consumer Products, and Dr Reddy’s Laboratories, are expected to record double-digit growth in their topline and bottomline figures for the March quarter due to healthy execution and strong order books. L&T’s core engineering business is expected to drive the topline with a healthy opening order book. Meanwhile, Revlimid, the cancer drug, is expected to have contributed significantly to growth in Dr Reddy’s US sales.
RVNL shares surge 7% after incorporating wholly-owned subsidiary in Andhra Pradesh
Rail Vikas Nigam Limited shares saw a surge. This followed the announcement of a new wholly owned subsidiary. The subsidiary is named Sabbavaram Sheelanagar Road